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Abstract
As the cross-cultural use of outcome measures grows, it is important to determine
whether these instruments are: appropriate for use in other settings, translated accu-
rately, and perform in a similar manner to their original tools. This research aimed to
compare the validity of the German translation of the ICECAP-A to the original
English version of the instrument, across healthy adults and seven health condition
groups (arthritis, asthma, cancer, depression, diabetes, hearing loss and heart disease).
Data were analysed from a cross-cultural study, which recruited participants through
online panels in 2012. Data were analysed on capability wellbeing (ICECAP-A),
health-related quality of life (EQ-5D-5L and SF-6D), satisfaction with life (SWLS),
and a series of other condition-specific outcome measures. The ICECAP-A was
assessed for internal consistency, convergent validity and construct validity. 2501
individuals were included in the analysis. The ICECAP-A demonstrated good internal
consistency within Germany and the UK population, and across all seven health
condition sub-groups (α = .74–.86). In both countries, ICECAP-A scores were signif-
icantly correlated with SWLS, SF-6D and EQ-5D-5L scores for healthy participants
and health condition groups (r = .35–.77). Finally, experiencing one of the seven health
conditions (compared to being healthy) was significantly associated with lower levels
of capability wellbeing in the German and UK samples (construct validity). The
German translation of the ICECAP-A yielded valid and reliable data, in both healthy
respondents and the seven health condition groups. Further work could be undertaken
to develop a German specific value-set for the ICECAP-A.
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Background
There is increasing pressure for economic evaluations to acknowledge the impact of
health and social care interventions on the wider aspects of wellbeing, above and beyond
health-related quality of life (Brazier and Tsuchiya 2015). Several western governments
have also sought to incorporate comparatively ‘subjective’ forms of wellbeing alongside
more ‘traditional’ economic indicators in their assessments of societal progress (Hicks
et al. 2013; Stiglitz et al. 2010). As the measurement of wellbeing continues to grow
(Linton et al. 2016), it becomes increasingly important to assess how well these tools are
able to perform across countries, populations and settings.
The ICECAP tools represent one approach to the measurement of wellbeing for use
in economic evaluations. These tools were influenced by the work of Nobel Prize
winning economist, Amartya Sen (Sen 1993), and conceptualise wellbeing in terms of
how capable a person is to achieve a personally valuable life (Coast et al. 2015). The
primary rationale for focussing on capability in the health field is a growing concern
that measures may be missing important aspects of quality of life; currently measures
used in health economic analysis tend to focus primarily on health (Coast et al. 2008b).
The ICECAP-O was the first generic measure of capability wellbeing for use across
patient populations used in health economics, and was specifically designed for use in
older-adults (i.e. 65 years old and over) (Coast et al. 2008a; Grewal et al. 2006).
Following this, ICECAP-A was developed for use in the general adult population (i.e.
18 years old and over) (Al-Janabi et al. 2012). ICECAP measures are now being
recommended for use in economic evaluations assessing interventions in social care
and long-term conditions, both in the UK where the ICECAP measures were originally
developed (National Institute for Health and Care Excellence 2014) but also interna-
tionally (Versteegh et al. 2016)
Given the impact of economic evaluations on policy and practice, it remains vital to
assess the quality of the instruments involved in this process (Mokkink et al. 2010).
Psychometric evidence provides a source of insight into the validity and reliability of
the measures in use, but these investigations are infrequently conducted across different
cultural settings. Nonetheless, experiences of health and wellbeing may differ between
countries and there is a need for internationally used instruments to be comparable and
applicable across cultures (Taggart et al. 2013).
A growing literature on the psychometric performance of the ICECAP tools exists.
In the UK, studies have demonstrated that the ICECAP-A is responsive to deteriora-
tions in clinical symptoms among women with irritative lower urinary tract symptoms
(Goranitis et al. 2016) and to changes in health-related quality of life following knee
pain (Keeley et al. 2015). Additionally, support has been found for the convergent
validity of the attributes within the ICECAP-Awith the attributes of the EQ-5D, in the
general population (Al-Janabi et al. 2013). Convergent validity describes the extent to
which scores produced by a new instrument are correlated with scores on comparable
(or conceptually identical) existing instruments (DeVon et al. 2007). Cross-culturally,
the ICECAP-O has demonstrated good convergent validity with existing measures in a
sample of post-hospitalised older adults in the Netherlands (Makai et al. 2013) and
among nursing home residents with dementia in Germany (Makai et al. 2014). Similar
studies have demonstrated the reliability and validity of the ICECAP-O in Spain
(Sarabia-Cobo et al. 2017) and Sweden (Hörder et al. 2016) and for the ICECAP-A
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in China (Tang et al. 2018). However, to date, the validity of a German translation of
the ICECAP-A has not been investigated. In addition, no translated ICECAP-A or
ICECAP-O measure has been directly compared to the original version using similar
population groups across different countries.
The challenge of translating instruments into different languages is critical to the use
of outcomes measures across countries. One of the central challenges here concerns the
extent to which questionnaire items will be interpreted in the same way across cultures,
and in alternative languages (Reeve et al. 2013). Specific guidance on the translation of
outcome measures highlights how poor translation may result in new measures that
misinterpret the concepts underpinning the original tools or violate the regular speech
patterns of the target language (Wild et al. 2005). In summary, the translation of
outcome measures requires careful consideration, in addition to an exploration of
psychometric properties.
The aim of this work was to quantitatively assess the psychometric compara-
bility of the newly translated German version of the ICECAP-A to the original
English language version. To further investigate the validity of the ICECAP-A
across contexts, this research investigates the psychometric performance of the tool
in healthy and health condition populations. Although ICECAP measures have
been translated into numerous languages, this is the first psychometric study to
simultaneously compare a translated ICECAP instrument in its country of use
(Germany) with the original English language version of the instrument in the
UK. This study will contribute to the growing literature of articles evaluating the
quality and applicability of capability wellbeing measures.
Methods
Dataset
This study used data collected as part of the Multi Instrument Comparison (MIC)
dataset, a large study of health and wellbeing measures collected across different
population groups and countries in 2012 (Richardson et al. 2015b). The survey
was conducted by a global panel company CINT Pty Ltd., using online panels to
recruit relevant individuals. Participants were classified into health condition
groups if they self-reported one of seven primary health conditions (asthma,
arthritis, cancer, depression, diabetes, hearing loss or heart disease). ‘Healthy’
participants were defined as those reporting 70 or higher on a 0–100 visual
analogue scale measuring overall health, and without any other illnesses lasting
longer than three months in the past year. This study utilised data collected in
Germany and the UK. Quotas were employed to obtain a representative sample in
terms of age, sex and education in the healthy population, while target quotas of
150 individuals per health condition group per country were employed to reach
similar numbers of health condition groups within and across countries. The
survey was approved by the Monash University Human Research Ethics Commit-
tee (reference number: CF11/3192–2,011,001,748). In addition to questions relat-
ed to health and wellbeing, standard sociodemographic data were collected (age,
sex, gender, educational attainment).
ICECAP-A German translation with English comparison
Measures
Capability Wellbeing
The ICECAP-A comprises five questionnaire items with four response levels each, and is
designed to capture people’s capability to live a life that they value (Al-Janabi et al. 2012).
These ‘capabilities’ are stability (feeling settled and secure), attachment (able to achieve
love, friendship and support), autonomy (able to be independent), achievement (able to
achieve and progress in life) and enjoyment (able to experience enjoyment and pleasure)
(Al-Janabi et al. 2012). The methodology used to convert raw scores into capability values
is described elsewhere (Flynn et al. 2015), however scores range from 0 which represents
‘no capability’ to 1 which represents ‘full capability’. In the absence of a scoring tariff for
both countries, UK scores were applied to the German and UK sample.
In accordance with available guidance on the topic, preparation for the translation
involved establishing a multi-lingual study team and undergoing a process of
familiarisation with the concepts of the ICECAP-A (Wild et al. 2005). Next, a first
language German speaker was identified by the Australian MIC study team to forward
translate the instrument. Plausibility and accuracy of this translation was undertaken in
collaboration with two members of the German MIC data collaborators (including MS)
prior to data collection. Subsequent to data collection, a back-translation was undertaken
by one German native with prolonged experience living in English speaking countries and
who did not have any knowledge of the ICECAP-A. The back-translated English version
was then compared with the German translation by an American native with prolonged
experience living in Germany, who also did not know the ICECAP-A, to check for any
literal and semantic mistakes. Semi-structured interviews were conducted by MS and JU,
who are both familiar with the ICECAP-A, with the aim to understand if there were
conceptual differences between the original ICECAP-A and the back translated version. It
was concluded that the semantic translation was conducted well, with little if any potential
for improvement on the translated version (further information available on request). Both
the original, and the translated version of the ICECAP-A are available through the
ICECAP project website (https://www.birmingham.ac.uk/ICECAP).
Health Status
The EQ-5D is the most common measure used in health economics to generate quality-
adjusted life years (QALYs) (Wisløff et al. 2014). The tool consists of five dimensions
(mobility, self-care, usual activities, pain/discomfort and anxiety/depression), with the
most recent version (EQ-5D-5L) consisting of five response levels per dimension (no
problems, slight problems, moderate problems, severe problems and extreme prob-
lems). English population values have been developed for the EQ-5D-5L (Devlin et al.
2017). Values are used to estimate the relative preferences for different health states as
measured by the concepts captured in the measure. Values on the EQ-5D-5L are
anchored on a 0–1 dead to full health scale, with values below zero possible (minimum
value for England EQ-5D-5L value set of −0.285). The EQ-5D-5L was translated into
German and validated in a previous study (Hinz et al. 2014). The English population
value-set for the EQ-5D-5L was applied to the UK and German sample in the absence
of a German value-set.
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The Short Form 36 (SF-36) is a widely used instrument for measuring generic health
status worldwide. It consists of 36 items that are compiled into eight sub-scales: vitality,
physical functioning, bodily pain, general health perceptions, physical role functioning,
emotional role functioning, social role functioning and mental health (Ware Jr and
Sherbourne 1992). For each of the eight sub-scales, scores are summed to a 0 (worst
health state) to 100 (best health state). The SF-36 was also previously translated into a
German language version and validated within an existing study (Bullinger 1995). SF-
6D scores were derived from responses to the SF-36 using econometric modelling
methods (Brazier et al. 2002) in line with previous studies using the Multi-Instrument
Comparison (MIC) dataset (Richardson et al. 2015a).
Satisfaction with Life
The Satisfaction with Life Scale (SWLS) was developed as a measure of ‘life satisfac-
tion’, a key component of subjective well-being (Diener et al. 1985). The scale consists
of five items and is scored on a five-point Likert scale (ranging from strongly disagree
to strongly agree). An overall scale score is calculated by summing the item scores;
higher scores indicate greater levels of life satisfaction. SWLS was chosen after
previous research in English speaking samples suggest subjective wellbeing measures
have comparable correlation with the ICECAP-A and the physical and mental health
subscales of the SF-36 (Richardson et al. 2016).
Condition Severity Measures
The severity of disease burden experienced by participants in each of the health
condition sub-samples was measured using the following condition specific tools:
Arthritis Impact Measurement Scales (Guillemin et al. 1997), Asthma Quality of Life
Questionnaire (Marks et al. 1992), European Organisation for Research and Treatment
of Cancer Quality of Life Questionnaire Cancer-30 (Aaronson et al. 1993), Depression
Anxiety and Stress Scale (Lovibond and Lovibond 1995), Diabetes-39 Questionnaire
(Boyer and Earp 1997), Abbreviated Profile of Hearing Aid Benefit (Cox and
Alexander 1995) and MacNew Heart Disease HRQL questionnaire (Höfer et al.
2004). Scores on these instruments were transformed into total scale scores ranging
from ‘0’ (low) to ‘1’ (severe) health condition severity. A full outline of the method
used to develop these scores has been detailed previously (Mitchell et al. 2015).
Statistical Analysis
All analyses were conducted using STATA 14. Descriptive statistics are used to report
the socio-demographic characteristics of the sample, split by country context and health
condition sub-sample. The psychometric analyses were split by country to test whether
the German translation of the ICECAP-A performs similarly to the original UK version
of the tool. Analyses were further split by health condition group, to test whether the
tool performed as well as expected across populations with a range of health conditions.
The internal consistency of ICECAP-Awas tested using Cronbach’s alpha, and refers to
the extent to which the items of an instrument are conceptually inter-related (Tavakol and
Dennick 2011). Although ICECAP-A is expected to assess five distinct components
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(stability, attachment, autonomy,achievementandenjoyment), itwouldbeuseful toexamine
the extent towhich the toolmeasures someunderlyingandunifyingconcept of ‘capabilities’.
Alpha scores range from ‘0 – 1’ and low scores indicate poor internal consistency, while
scores of ‘.7’ or higher indicate satisfactory internal consistency (Bland andAltman 1997).
To assess convergent validity, Pearson’s correlation coefficients between scores for
the ICECAP-A and related measures of health-related quality of life and wellbeing
were calculated (EQ-5D-5L, SF-6D and SWLS). Correlations between the ICECAP-A
and other measures are considered strong if over ‘0.5’, moderate if between ‘0.3’ and
‘0.5’ and weak if less than ‘0.3’ (Cohen 1988).
Construct validity describes a broad range of measurement concerns; however,
overall it concerns investigations into the relationships between scores on a measure
with other variables that it theoretically should be associated with (Westen and
Rosenthal 2003). A central component of construct validation is ongoing hypothesis
testing concerning other questionnaire instruments or between sub-groupings of re-
spondents (De Vet et al. 2011). In line with guidance, we investigated the ability of the
ICECAP-A to differentiate between groups hypothesised to differ in their levels of the
construct capability-wellbeing (the healthy sub-sample, compared to respondents
reporting one of the seven primary healthy conditions).
Construct validity was assessed using a two-stage process. Firstly, ordinary least
squares (OLS) regression methods were used to test whether type of health condition
(reporting the presence of one of seven primary health conditions compared to being
healthy) had a significant association with capability scores, controlling for age, gender
and educational level. Although previous research has employed exploratory factor
analysis to validate ICECAP measures compared to other health measures (Davis et al.
2013; Keeley et al. 2016; Engel et al. 2017), our research question required a method to
compare the performance of two versions of ICECAP simultaneously. Previous re-
search has demonstrated that OLS models perform well in health-related quality of life
outcome studies (Al-Janabi et al. 2017), and studies with capability wellbeing measures
(Mitchell et al. 2013; Mitchell et al. 2017b; Franklin et al. 2018). Secondly, the sample
was split into the seven health condition groups, and follow-up OLS analyses were
conducted to examine the associations between health condition severity and capability
wellbeing for each of the health conditions, controlling for demographic differences
(age, gender and education). This analysis was undertaken to explore the associations
between health condition within each of the health condition groups, rather than to
provide a directly comparable indicator of severity between conditions.
Results
Sample Characteristics
Missing data were found for a very small proportion of the respondents (0.08%, 2/2503),
therefore data were only analysed for complete cases (N = 2501). The descriptive
characteristics of this sample are presented in Table 1. The German sample (N = 1212)
and UK sample (N = 1289) are further split into healthy and health condition group sub-
samples. The youngest respondents were found in the depression sub-sample and the
oldest respondents were found in the heart disease sub-sample across the German and
M.-J. Linton et al.
UK samples. Similarly, the depression sub-sample contained the most female respon-
dents while the heart disease sub-sample contained the most males in both the German
and UK samples. The cancer sub-sample had the highest level of university attendance
in the German sample, while people with Asthma had the highest educational level in
the UK data. Finally, across Germany and the UK, ICECAP-A scores were highest
amongst healthy respondents and lowest amongst respondents with depression.
The characteristics of respondents who scored at different levels of the five
ICECAP-A attributes are described in Table 2. In the German sample, there were
comparatively higher scores for achievement, while in the UK sample, over 50% of the
sample indicated that they experienced the highest level of autonomy. Levels of life
Table 1 Sample descriptive characteristics – German sample and UK sample
Sample
N = sample size
Sub-sample
n = sub-sample
Age
Mean (SD)
Gender
% female
Education
% University
ICECAP-A
Mean (SD)
Germany
N = 1212
Healthy
n = 203
44.90 (15.20) 51.72 14.29 .883 (.114)
Arthritis
n = 159
52.40 (9.54) 53.16 18.35 .766 (.175)
Asthma
n = 147
42.95 (15.80) 60.00 41.33 .812 (.171)
Cancer
n = 115
53.38 (13.24) 56.93 38.69 .792 (.185)
Depression
n = 160
42.16 (12.62) 63.39 34.81 .595 (.224)
Diabetes
n = 140
52.86 (12.78) 32.30 29.81 .766 (.211)
Hearing problems
n = 136
51.31 (11.86) 47.62 36.51 .830 (.169)
Heart disease
n = 152
55.38 (11.50) 31.74 25.75 .789 (.197)
UK
N = 1289
Healthy
n = 234
45.92 (16.05) 49.15 30.34 .877 (.135)
Arthritis
n = 158
58.27 (11.25) 52.83 23.27 .799 (.153)
Asthma
n = 150
41.31 (15.80) 48.98 25.85 .846 (.134)
Cancer
n = 137
59.91 (11.42) 45.22 38.26 .785 (.184)
Depression
n = 158
38.94 (13.17) 60.63 16.25 .613 (.205)
Diabetes
n = 161
57.25 (12.29) 36.43 32.14 .817 (.181)
Hearing problems
n = 124
55.27 (17.43) 47.58 37.10 .831 (.169)
Heart disease
n = 167
59.17 (14.02) 34.21 32.24 .795 (.185)
SD Standard deviation
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satisfaction (SWLS) and health-related quality of life (EQ-5D-5 L) were also examined
for participants scoring at different levels of the ICECAP-A attributes. In Germany and
the UK, the highest mean SWLS scores were found for respondents with the highest
levels of ‘Stability’. Similarly, in both samples, the highest mean EQ-5D scores were
found in respondents with the highest levels of ‘Achievement’.
Internal Consistency Reliability
Cronbach’s alpha was calculated separately for the German and UK samples and is
presented in Table 3. The German translation of the ICECAP-A demonstrated good
Table 2 Percentage of respondents at each ICECAP-A response level, and their mean SWLS and EQ-5D-5 L
scores
Respondents at each
level of the ICECAP-A - %
SWLS scores -
Mean (SD)
EQ-5D scores -
Mean (SD)
Attributes and levels Germany UK Germany UK Germany UK
Stability
Level 4 29% 19% .707 (.010) 0.737 (.011) .909 (.007) .904 (.008)
Level 3 52% 48% .561 (.008) 0.583 (.008) .811 (.007) .832 (.007)
Level 2 17% 25% .299 (.013) 0.344 (.011) .614 (.016) .658 (.014)
Level 1 2% 7% .248 (.036) 0.139 (.016) .502 (.039) .528 (.031)
Attachment
Level 4 36% 43% .680 (.009) 0.637 (.009) .864 (.008) .837 (.009)
Level 3 42% 37% .554 (.009) 0.511 (.010) .812 (.008) .779 (.010)
Level 2 20% 17% .349 (0.13) 0.288 (.014) .676 (.015) .669 (.017)
Level 1 2% 2% .222 (.036) 0.167 (.040) .583 (.039) .512 (.050)
Autonomy
Level 4 37% 53% .639 (.010) 0.572 (.010) .882 (.007) .883 (.004)
Level 3 46% 34% .554 (.009) 0.496 (.012) .801 (.008) .755 (.010)
Level 2 15% 11% .357 (.016) 0.385 (.020) .627 (.018) .460 (.023)
Level 1 2% 2% .302 (.050) 0.342 (.058) .454 (.066) .245 (.074)
Achievement
Level 4 27% 21% .696 (.011) 0.702 (.012) .919 (.006) .915 (.006)
Level 3 49% 47% .571 (.009) 0.577 (.008) .828 (.007) .844 (.006)
Level 2 22% 26% .375 (.013) 0.349 (.012) .626 (.014) .638 (.014)
Level 1 3% 6% .213 (.029) 0.209 (.023) .499 (.045) .441 (.033)
Enjoyment
Level 4 26% 33% .692 (.011) 0.689 (.009) .903 (.007) .895 (.006)
Level 3 49% 39% .586 (.009) 0.540 (.009) .838 (.006) .807 (.008)
Level 2 23% 26% .354 (.012) 0.302 (.011) .629 (.013) .615 (.015)
Level 1 2% 2% .169 (.030) 0.098 (.036) .464 (.045) .450 (.064)
Attributes refer to each of the domains within the ICECAP-A
The four levels within the attributes range from having full capability (4) to having no capability (1)
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internal consistency (α = .83) and was comparable with the internal consistency of the
scale in the UK data (α = .85). When internal consistency was assessed separately for
each health condition group the scale was found to be similarly reliable (Germany:
α = .74–.86, UK: α = .78–.86).
Convergent Validity
Correlation coefficients highlighting the relationships between the ICECAP-A and
three related tools are presented in Table 4. All of the correlation coefficients were
Table 3 Internal consistency
(Cronbach’s alpha - α) of the
ICECAP-A across sub-samples
Germany UK
Overall sample .83 .85
Healthy .78 .80
Arthritis .74 .78
Asthma .77 .83
Cancer .86 .83
Depression .78 .79
Diabetes .83 .86
Hearing loss .74 .84
Heart disease .83 .85
Table 4 Correlation coefficents between the ICECAP-A and three related measures across sub-samples
Samplesa EQ-5D-5 L SWLS SF-6D
Germany Overall sample .62 .66 .64
Healthy .35 .61 .47
Arthritis .53 .58 .64
Asthma .61 .52 .56
Cancer .57 .70 .57
Depression .48 .54 .56
Diabetes .55 .62 .57
Hearing loss .58 .60 .57
Heart disease .66 .66 .70
UK Overall sample .61 .68 .65
Healthy .36 .63 .40
Arthritis .64 .57 .66
Asthma .43 .65 .54
Cancer .68 .67 .70
Depression .57 .64 .59
Diabetes .60 .67 .60
Hearing loss .58 .77 .61
Heart disease .68 .66 .73
(All coefficients were statistically significant (p < .001))
a Samples sizes are stated in Table 1
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statistically significant (p < .001) and positive in direction. In the German sample, all of
the correlation coefficients were moderate to large in size (r ≥ .3). These results
demonstrate that scores on the German translation of the ICECAP-A converge with
scores on measures of health-related quality of life and wellbeing, and that this
convergence is generalizable across sub-populations. These results were comparable
to the results yielded with the English language version of the ICECAP-A in the UK
sample. One notable difference in results across study populations was that capabilities
Table 5 Correlation coefficents between the ICECAP-A and dimension level scores on the EQ-5D-5 L,
SWLS and SF-36, in Germany and the UK
Country context Dimensionsa ICECAP-A attributes
Stability Attachment Autonomy Achievement Enjoyment
Germany EQ-5D Mobility 0.28 0.19 0.33 0.40 0.31
EQ-5D Self-care 0.29 0.25 0.33 0.33 0.31
EQ-5D Usual activities 0.42 0.30 0.43 0.53 0.45
EQ-5D Pain 0.31 0.19 0.27 0.37 0.35
EQ-5D Anxiety/Depression 0.61 0.47 0.42 0.53 0.55
SWLSb 0.57 0.53 0.39 0.52 0.54
SF Physical functioning 0.33 0.24 0.36 0.45 0.36
SF Role-Physical 0.39 0.27 0.34 0.46 0.38
SF Bodily pain 0.37 0.22 0.30 0.41 0.39
SF General health 0.44 0.32 0.36 0.50 0.45
SF Vitality 0.57 0.41 0.45 0.60 0.53
SF Social functioning 0.54 0.48 0.40 0.53 0.51
SF Role-emotional 0.51 0.37 0.41 0.48 0.46
SF Mental health 0.64 0.49 0.44 0.56 0.58
UK EQ-5D Mobility 0.27 0.16 0.54 0.39 0.32
EQ-5D Self-care 0.25 0.13 0.53 0.36 0.29
EQ-5D Usual activities 0.33 0.20 0.60 0.47 0.39
EQ-5D Pain 0.27 0.15 0.45 0.37 0.29
EQ-5D Anxiety/Dep 0.65 0.48 0.39 0.57 0.60
SWLSb 0.67 0.52 0.25 0.57 0.62
SF Physical functioning 0.27 0.14 0.55 0.41 0.33
SF Role-Physical 0.27 0.20 0.38 0.34 0.33
SF Bodily pain 0.32 0.17 0.47 0.41 0.33
SF General health 0.44 0.31 0.49 0.52 0.49
SF Vitality 0.57 0.40 0.43 0.58 0.60
SF Social functioning 0.54 0.38 0.53 0.54 0.56
SF Role-emotional 0.46 0.33 0.38 0.42 0.45
SF Mental health 0.69 0.52 0.39 0.60 0.67
(All coefficients were statistically significant (p < .001))
a Higher levels of health related quality of life (EQ-5D-5L and SF-6D), and higher levels of life satisfaction
(SWLS) a b correlations between the ICECAP-A and were not conducted with the SWLS at item level, as the five
questions in this scale measure a single dimension (life satisfaction).
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(ICECAP-A) were more related to life satisfaction (SWLS) than health-related quality
of life (EQ-5D-5 L and SF-6D) among healthy respondents in the German and UK
study samples.
Correlation coefficients between the ICECAP-A attributes and the dimensions
within these three outcome measures for the overall samples in Germany and the UK
are presented in Table 5. In both country contexts, SWLS scores had good correlation
with most ICECAP-A attributes in both countries, except for the autonomy attribute.
The anxiety/depression dimension on EQ-5D-5L had good correlation with all
ICECAP-A attributes, with only the autonomy attribute on ICECAP-A having higher
correlation with usual activities on EQ-5D-5L across both countries. For SF-36, the
dimensions of vitality, social functioning and mental health also had good correlations
across all ICECAP-A attributes in both countries.
Table 6 OLS regressions examining the associations between each of the health conditions and capability
scores
OLS regression in German sample OLS regression in UK sample
Coef.
(SE)
Lower
95% CI
Upper
95% CI
Coef.
(SE)
Lower
95% CI
Upper
95% CI
Socio-Demographics
Age .001*
(.000)
.000 .002 .001**
(.000)
.001 .002
Gender (Female) −.003
(.010)
−.022 .015 .001
(.011)
−.020 .021
Education (University) .054***
(.011)
.033 .075 .027*
(.011)
.005 .048
Health conditions
Arthritis −.095***
(.017)
−.129 −.061 −.123***
(.019)
−.161 −.085
Asthma −.041*
(.017)
−.075 −.007 −.063**
(.019)
−.100 −.025
Cancer −.119***
(.019)
−.156 −.081 −.105***
(.020)
−.145 −.065
Depression −.267***
(.017)
−.301 −.234 −.274***
(.019)
−.311 −.237
Diabetes −.083***
(.018)
−.118 −.048 −.125***
(.019)
−.163 −.088
Hearing loss −.065***
(.018)
−.100 −.029 −.060**
(.021)
−.100 −.019
Heart disease −.107***
(.018)
−.142 −.073 −.104***
(.019)
−.141 −.067
_cons 0.840 .811
R2 .21 .18
N 1212 1289
Dependent variable ICECAP-A scores, Coef. Regression coefficient, SE Standard error, CI 95% Confidence
interval, *p < .05, **p < .01 and ***p < .001
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Construct Validity
The effects of experiencing one of the seven health conditions (compared to being in the
healthy sub-sample) on capability wellbeing are presented in Table 6. The coefficients
from the OLS regression indicate that in the German sample, the presence of any of the
seven of the health conditions had a significantly negative impact on capability scores,
controlling for socio-demographic characteristics. Depression (β = −.267, p < .001),
followed by cancer (β = −.119, p < .001) and heart disease (β = −.107, p < .001) had the
strongest effects on capabilities, while the smallest effect was for the presence of asthma
(β = −.041, p < .05). The seven health conditions were also associated with significantly
lower levels of capability wellbeing in the UK sample, in which depression also had the
strongest detrimental effect (β = −.274, p < .001). The R2 statistics indicate that the
Table 7 Summary table of regression coefficients indicating the impact of condition-specific severity on
capabilities, controlling for socio-demographics (age, gender and education) across health condition groups in
Germany and the UK
Country Condition severity
n = sub-sample
Coef.
(SE)
Lower 95% CI Upper 95% CI
Germany Arthritis
n = 159
−0.556***
(0.075)
−0.704 −0.408
Asthma
n = 147
−0.305***
(0.048)
−0.400 −0.210
Cancer
n = 115
−0.409***
(0.062)
−0.532 −0.286
Depression
n = 160
−0.499***
(0.067)
−0.631 −0.366
Diabetes
n = 140
−0.396***
(0.062)
−0.519 −0.272
Hearing problems
n = 136
−0.170*
(0.067)
−0.303 −0.036
Heart disease
n = 152
−0.673***
(0.053)
−0.778 −0.567
United Kingdom Arthritis
n = 158
−0.593***
(0.086)
−0.759 −0.481
Asthma
n = 150
−0.620***
(0.070)
−0.764 −0.423
Cancer
n = 137
−0.502***
(0.052)
−0.606 −0.399
Depression
n = 158
−0.628***
(0.063)
−0.752 −0.503
Diabetes
n = 161
−0.429***
(0.069)
−0.566 −0.292
Hearing problems
n = 124
−0.313***
(0.076)
−0.464 −0.163
Heart disease
n = 167
−0.747***
(0.053)
−0.852 −0.641
Dependent variable ICECAP-A scores, Coef. Regression coefficient, SE Standard error, CI 95% Confidence
interval, *p < .05, **p < .01 and ***p < .001
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demographics and health conditions accounted for approximately a fifth of the variance in
ICECAP-A scores (Germany = 21% and UK= 18%).
Finally, the sample was split by health condition group to determine the extent to
which condition-specific severity had a negative association with ICECAP-A scores
within the seven health condition groups. The OLS regression coefficients for health
condition severity in each of the separate health condition groups are presented in
Table 7 (Appendix 1 and 2: Full description of the individual regression analyses). In
each of the German health condition groups, health condition severity had a significant
negative impact on capability wellbeing, most notably for heart disease (β = −.673,
p < .001), arthritis (β = −.556, p < .001) and depression (β = −.499, p < .001). A similar
pattern of results was observed for the UK health condition groups.
Discussion
Summary of Main Findings
This study set out to determine whether the German translation of the ICECAP-A is
psychometrically valid, and capable of yielding results comparable to the previously vali-
dated original UK version of the tool. The German ICECAP-A demonstrated good internal
consistency and good convergent validity when compared to existing measures of health-
related quality of life and satisfactionwith life. Further, scores on the newly translated version
of the tool were significantly lower amongst respondents reporting one of the seven studied
health condition groups (compared to being healthy). Finally, the results yielded by the
German translation of the ICECAP-A used in the German sample were largely comparable
to the results yielded by the original English language version of the tool used in the UK.
Interpretation of Findings
The findings from this study contribute to the growing literature concerning the psychomet-
ric validity of ICECAPmeasures across cultural contexts. The ICECAP-A also demonstrat-
ed convergent validity with the SWLS and SF-6D, suggesting that it is able to capture
elements of a person’s health-related quality of life, but alsowider aspects of subjective well-
being. This work also extends existing cross-cultural (Australia, Canada, UK and US)
insight on the detrimental impact of depression on capabilities to a German context
(Mitchell et al. 2015). Meeting the challenges caused bymental health difficulties in Europe
has become a widely recognised policy priority (World Health Organization 2008).
Strengths and Limitations
The key strength of this study is its utilisation of data collected from participants reporting a
variety of health conditions, from multiple country contexts. It represents the first study to
validate a translated ICECAP measure across countries compared to the original version.
Further, evidence is presented for multiple psychometric properties, indicating a compre-
hensive description of both validity and reliability. There are, however also some limitations.
In particular, the pragmatic nature of the study meant that formal back-translation of the
measure was not undertaken until after the data collectionwas conducted. A further caveat is
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that due to the use of cross-sectional data, further research is needed to establish the causality
of the significant relationships identified. It should also be noted that there were some socio-
demographic differences in the participants between the samples in the German and UK
data. Reliance on aUKvalue set to demonstrate the validity of the German translation is also
not ideal, but necessary given no value set for ICECAP-A currently exists outside the
country of origin (Flynn et al. 2015). In addition, there is no “gold-standard” for the
measurement of capability wellbeing, with the ICECAP-A representing one of the first
attempts to directly measure self-reported capability (Mitchell et al. 2017a). Validity assess-
ment in this study relies on common measures of health status currently used in health
economics and a measure of subjective wellbeing. Finally, condition severity is measured
using condition-specific measures in each health condition group, therefore the follow-up
OLS results highlight the importance of condition severity within conditions, rather than
differences in the importance of severity between conditions.
Implications
This study demonstrates that the German translation of the ICECAP-A performs
similarly to the original English version of the tool and is able to collect reliable and
valid data when applied in a German setting. This study therefore provides initial
evidence that the ICECAP-A capability measure may be appropriate to be used in
countries outside where the measure was developed. Specifically, this paper provides
evidence for German decision makers to recommend the use of the ICECAP-A in
economic evaluations, as has been previously done for the ICECAP-O in the Nether-
lands for evaluations of long-term conditions (Versteegh et al. 2016).
Future Research
Although this study presents evidence of the validity of the German translated
ICECAP-A, there are a number of questions that remain unaddressed in the use of
translated capability measures. Two main areas that need to be addressed concern the
appropriateness of the ICECAP-A descriptive and valuation system outside of the UK.
This question is not only aimed at countries where English is not the first language, as
both the specific capabilities that are important and how they are valued could vary in
both English and non-English speaking settings.
In terms of further validation of the German translated ICECAP-A, ongoing research is
needed to establish whether the German translation of the ICECAP-A performs well when
tested for additional psychometric properties. For example, a longitudinal study design
would enable researchers to explore whether scores are stable across reasonable durations of
time (test re-test reliability) and whether scores are sensitive to changes in life circumstances
and health status (responsiveness).
Conclusion
This is the first paper to provide psychometric evidence that simultaneously compares a
translated ICECAP instrument in its country of use (Germany) with the original English
language version of the instrument in the UK. Although the current study is based on cross-
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sectional data, the results indicate that the German translation of the ICECAP-Ayields valid
and reliable data and is comparable to the original English language version of the tool. This
study adds to growing body of literature on the psychometric properties of the ICECAP-A,
whilst also extending our understanding of the relationship between condition severity and
capability wellbeing.
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Appendix 1
OLS regression analyses investigating the impact of disease severity on capabilities
(using the German translation of the ICECAP-A in Germany) in six patient populations
Table 8 OLS regression analysis investigating the association between Arthritis Impact Measurement scores on
capability wellbeing (using the German translation of the ICECAP-A in Germany) in the arthritis disease-group
Coef. Std. Err. t P > t [95% Conf. Interval]
Age 0.002 0.001 1.420 0.157 −0.001 0.004
Gender 0.012 0.021 0.570 0.567 −0.030 0.054
Education (University) 0.028 0.025 1.120 0.262 −0.021 0.077
Arthritis severity −0.556 0.075 7.430 0.000 −0.704 −0.408
_cons 0.322 0.083 3.870 0.000 0.157 0.486
R-squared = 0.2909
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Table 9 OLS regression analysis investigating the association between Asthma Quality of Life Questionnaire
scores on capability wellbeing (using the German translation of the ICECAP-A in Germany) in the asthma
disease-group
Coef. Std. Err. t P [95% Conf. Interval]
Age 0.000 0.001 0.08 0.940 −0.001 0.001
Gender −0.015 0.020 −0.76 0.450 −0.054 0.024
Education (University) −0.007 0.023 −0.31 0.759 −0.054 0.039
Asthma severity −0.305 0.048 6.35 0.000 −0.400 −0.210
_cons 0.686 0.059 11.72 0.000 0.571 0.802
R-squared = 0.2506
Table 10 OLS regression analysis investigating the association between European Organisation for Research
and Treatment of Cancer Quality of Life Questionnaire Cancer-30 scores on capability wellbeing (using the
German translation of the ICECAP-A in Germany) in the cancer disease-group
Coef. Std. Err. t P > t [95% Conf. Interval]
Age 0.000 0.001 −0.080 0.933 −0.002 0.002
Gender 0.016 0.030 0.520 0.603 −0.045 0.076
Education (University) 0.071 0.030 2.400 0.018 0.012 0.129
Cancer severity −0.409 0.062 6.590 0.000 −0.532 −0.286
_cons 0.501 0.088 5.700 0.000 0.327 0.675
R-squared = 0.3467
Table 11 OLS regression analysis investigating the association between Depression Anxiety and Stress Scale
scores on capability wellbeing (using the German translation of the ICECAP-A in Germany) in the depression
disease-group
Coef. Std. Err. t P > t [95% Conf. Interval]
Age 0.002 0.001 1.680 0.095 0.000 0.004
Gender 0.017 0.029 0.570 0.571 −0.041 0.074
Education (University) 0.028 0.038 0.720 0.470 −0.048 0.103
Depression severity −0.499 0.067 7.440 0.000 −0.631 −0.366
_cons 0.259 0.083 3.120 0.002 0.095 0.423
R-squared = 0.2838
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Table 12 OLS regression analysis investigating the association between Diabetes-39 Questionnaire scores on
capability wellbeing (using the German translation of the ICECAP-A in Germany) in the diabetes disease-
group
Coef. Std. Err. t P > t [95% Conf. Interval]
Age 0.000 0.001 0.030 0.973 −0.002 0.002
Gender −0.014 0.028 −0.490 0.627 −0.069 0.042
Education (University) 0.029 0.030 0.970 0.336 −0.030 0.087
Diabetes severity −0.396 0.062 6.360 0.000 −0.519 −0.272
_cons 0.562 0.082 6.840 0.000 0.400 0.725
R-squared = 0.2615
Table 13 OLS regression analysis investigating the association between Abbreviated Profile of Hearing Aid
Benefit scores on capability wellbeing (using the German translation of the ICECAP-A in Germany) in the
hearing loss disease-group
Coef. Std. Err. t P > t [95% Conf. Interval]
Age 0.000 0.001 −0.480 0.633 −0.003 0.002
Gender −0.011 0.025 −0.440 0.659 −0.059 0.038
Education (University) 0.014 0.024 0.570 0.566 −0.034 0.062
Hearing loss severity −0.170 0.067 −2.520 0.013 −0.303 −0.036
_cons 0.925 0.070 13.200 0.000 0.786 1.063
R-squared = 0.0593
Table 14 OLS regression analysis investigating the association between MacNew Heart Disease HRQL
questionnaire scores on capability wellbeing (using the German translation of the ICECAP-A in Germany) in
the heart disease group
Coef. Std. Err. t P > t [95% Conf. Interval]
Age 0.001 0.001 0.810 0.421 −0.001 0.003
Gender 0.043 0.022 1.920 0.057 −0.001 0.087
Education (University) 0.028 0.023 1.190 0.236 −0.018 0.073
Heart disease severity −0.673 0.053 12.590 0.000 −0.778 −0.567
_cons 0.234 0.069 3.390 0.001 0.098 0.370
R-squared = 0.5558
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Appendix 2
OLS regression analyses investigating the impact of disease severity on capabilities
(using the ICECAP-A in the UK) in six patient populations
Table 15 OLS regression analysis investigating the association between Arthritis Impact Measurement scores
on capability wellbeing (using the ICECAP-A in the UK) in the arthritis disease-group
Coef. Std. Err. t P > t [95% Conf. Interval]
Age 0.000 0.001 0.420 0.674 −0.001 0.002
Gender 0.057 0.025 2.240 0.026 0.007 0.107
Education (University) 0.033 0.025 1.310 0.192 −0.017 0.082
Arthritis severity −0.593 0.086 6.880 0.000 −0.764 −0.423
_cons 0.171 0.107 1.600 0.112 −0.040 0.382
R-squared = 0.2627
Table 16 OLS regression analysis investigating the association between Asthma Quality of Life Question-
naire scores on capability wellbeing (using the ICECAP-A in the UK) in the asthma disease-group
Coef. Std. Err. t P [95% Conf. Interval]
Age 0.000 0.001 0.420 0.674 −0.001 0.002
Gender 0.057 0.025 2.240 0.026 0.007 0.107
Education (University) 0.033 0.025 1.310 0.192 −0.017 0.082
Asthma severity −0.593 0.086 6.880 0.000 −0.764 −0.423
_cons 0.171 0.107 1.600 0.112 −0.040 0.382
0.000 0.001 0.420 0.674 −0.001 0.002
R-squared = 0.2627
Table 17 OLS regression analysis investigating the association between European Organisation for Research
and Treatment of Cancer Quality of Life Questionnaire Cancer-30 scores on capability wellbeing (using the
ICECAP-A in the UK) in the cancer disease-group
Coef. Std. Err. t P > t [95% Conf. Interval]
Age 0.002 0.001 1.990 0.049 0.000 0.004
Gender 0.003 0.025 0.130 0.899 −0.046 0.052
Education (University) 0.004 0.025 0.160 0.873 −0.045 0.053
Cancer severity −0.502 0.052 9.610 0.000 −0.606 −0.399
_cons 0.316 0.090 3.520 0.001 0.138 0.494
R-squared = 0.4533
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Table 18 OLS regression analysis investigating the association between Depression Anxiety and Stress Scale
scores on capability wellbeing (using the ICECAP-A in the UK) in the depression disease-group
Coef. Std. Err. t P > t [95% Conf. Interval]
Age −0.001 0.001 −0.910 0.363 −0.003 0.001
Gender 0.020 0.030 0.660 0.509 −0.039 0.078
Education (University) 0.025 0.030 0.840 0.402 −0.034 0.083
Depression severity −0.628 0.063 9.960 0.000 −0.752 −0.503
_cons 0.269 0.080 3.350 0.001 0.110 0.427
R-squared = 0.3993
Table 19 OLS regression analysis investigating the association between Diabetes-39 Questionnaire scores on
capability wellbeing (using the ICECAP-A in the UK) in the diabetes disease-group
Coef. Std. Err. t P > t [95% Conf. Interval]
Age 0.000 0.001 −0.360 0.716 −0.003 0.002
Gender 0.041 0.033 1.260 0.211 −0.024 0.107
Education (University) 0.004 0.033 0.130 0.901 −0.061 0.070
Diabetes severity −0.429 0.069 6.180 0.000 −0.566 −0.292
_cons 0.445 0.101 4.410 0.000 0.246 0.644
R-squared = 0.2110
Table 20 OLS regression analysis investigating the association between Abbreviated Profile of Hearing Aid
Benefit scores on capability wellbeing (using the ICECAP-A in the UK) in the hearing loss disease-group
Coef. Std. Err. t P > t [95% Conf. Interval]
Age 0.002 0.001 1.760 0.081 0.000 0.003
Gender −0.026 0.030 −0.880 0.382 −0.085 0.033
Education (University) 0.020 0.030 0.670 0.501 −0.039 0.080
Hearing loss severity −0.313 0.076 −4.130 0.000 −0.464 −0.163
_cons 0.905 0.087 10.450 0.000 0.733 1.076
R-squared = 0.1996
Table 21 OLS regression analysis investigating the association between MacNew Heart Disease HRQL
questionnaire scores on capability wellbeing (using the ICECAP-A in the UK) in the heart disease group
Coef. Std. Err. t P > t [95% Conf. Interval]
Age 0.000 0.001 −0.210 0.838 −0.002 0.001
Gender 0.000 0.023 0.000 0.997 −0.045 0.045
Education (University) −0.005 0.024 −0.200 0.843 −0.053 0.043
Heart disease severity −0.747 0.053 14.020 0.000 −0.852 −0.641
_cons 0.295 0.069 4.290 0.000 0.159 0.431
R-squared = 0.5507
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